Australia markets open in 2 hours 4 minutes

Universe Pharmaceuticals INC (UPC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.5000+0.0750 (+3.09%)
At close: 04:00PM EDT
2.5100 +0.01 (+0.40%)
After hours: 04:48PM EDT

Universe Pharmaceuticals INC

265, Jingjiu Avenue
Jinggangshan Eco & Tech Dev Zn
Ji'An 343100
China
86 79 6840 3309
https://www.universe-pharmacy.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees225

Key executives

NameTitlePayExercisedYear born
Mr. Gang LaiCEO & ChairmanN/AN/A1968
Ms. Lin YangCFO & DirectorN/AN/A1976
Mr. Baochang LiuChief Operating OfficerN/AN/A1980
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

Corporate governance

Universe Pharmaceuticals INC’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.